Online citations, reference lists, and bibliographies.
← Back to Search

Novel Core-shell Lipid-chitosan And Lipid-poloxamer Nanocapsules: Stability By Hydration Forces

M. J. Santander-Ortega, María V. Lozano-López, D. Bastos-González, J. M. Peula-García, J. L. Ortega-Vinuesa
Published 2010 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
In the last few years, a great attention has been paid to core-shell structured lipid nanocapsules. The interest of these colloids lies in their very promising applications as delivery systems of hydrophobic drugs or as DNA carriers. The aim of this work was to provide fuller knowledge concerning the physicochemical properties of these new colloidal particles, paying special attention to the role played by the constituting components. Our lipid nanocapsules were comprised of a triglyceride-lecithin core surrounded by a chitosan and/or poloxamer (Pluronic® F68) shell. Four different systems were formulated by varying the chitosan and poloxamer contents. We have estimated their shell composition from electrokinetic mobility measurements and stability studies. They revealed a high incorporation of chitosan to the shell, while Pluronic® F68 only presented a secondary role during the nanocapsule formation, providing final systems with low poloxamer content. In addition, the stability studies, performed not only on ideal solutions but also on simulated physiological fluids, revealed that hydration forces were crucial to maintain the integrity of these nanocapsules under physicochemical conditions similar to those found in real physiological fluids. Theoretical treatment of stability data has allowed us to determine the role that ions play on hydration forces when they act as counterions.
This paper references
10.3109/03639049809108571
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
10.1016/0378-5173(89)90281-0
Nanocapsule formation by interfacial polymer deposition following solvent displacement
H. Fessi (1989)
10.1016/J.COLSURFB.2007.06.002
Electrophoretic mobility and colloidal stability of PLGA particles coated with IgG.
M. J. Santander-Ortega (2007)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1016/J.COLSURFA.2006.09.036
Stability and physicochemical characteristics of PLGA, PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: A comparative study
M. J. Santander-Ortega (2007)
10.1016/J.JCONREL.2007.09.011
Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock.
S. H. Lee (2008)
10.1016/b978-0-12-391927-4.10024-6
Intermolecular and surface forces
J. Israelachvili (1985)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
10.1016/J.JCONREL.2005.12.015
Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
C. Prego (2006)
10.1016/0021-9797(73)90178-1
Kinetics of flocculation of latex particles by human gamma globulin
J. Singer (1973)
10.1163/156856298X00271
Modelling the kinetics of antigen-antibody reactions at particle enhanced optical immunoassays.
M. Quesada (1998)
10.1016/J.JCONREL.2007.10.002
Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel.
L. Y. Lee (2008)
10.1016/J.IJPHARM.2006.06.036
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction.
F. Sonvico (2006)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1021/LA962135H
Comparative Study on the Colloidal Stability Mechanisms of Sulfonate Latexes
J. M. Peula (1997)
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
A. Gabizon (1994)
10.1007/BF01341386
Über die Stabilität und Aufladung der Aerosole
N. Fuchs (1934)
10.1021/BM0608939
Oil-encapsulating PEO-PPO-PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel.
K. H. Bae (2007)
10.1016/0001-8686(82)85003-3
Strong and weak points in the interpretation of colloid stability
J. Theodoor (1982)
10.1007/S003960050050
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
10.1023/A:1012126301290
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
M. P. Desai (2004)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1166/JNN.2006.444
Surface-modified and conventional nanocapsules as novel formulations for parenteral delivery of halofantrine.
V. Mosqueira (2006)
10.1007/s11095-006-9662-5
Long Circulating Poly(Ethylene Glycol)-Decorated Lipid Nanocapsules Deliver Docetaxel to Solid Tumors
M. Khalid (2006)
10.1016/0378-5173(89)90272-X
An in vitro study of possible food-drug interactions of the controlled-release propranolol products
S. K. el-Arini (1989)
10.1007/s000180300002
Colloidal drug carriers: achievements and perspectives
G. Barratt (2003)
10.1021/LA034410N
Static Light Scattering Studies on Chitosan Solutions: From Macromolecular Chains to Colloidal Dispersions
C. Schatz (2003)
10.1016/0168-3659(95)00129-8
Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs
A. Berthold (1996)
10.1016/J.EJPB.2006.11.009
A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes.
K. Letchford (2007)
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
D. Drummond (1999)
10.1021/bm800298u
Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.
M. Lozano (2008)
10.1016/0021-9797(85)90062-1
Polyelectrolyte adsorption: II. Comparison of experimental results for polystyrene sulfonate, adsorbed on polyoxymethylene crystals, with theoretical predictions
J. Papenhuijzen (1985)
10.1021/J100823A028
DETECTION OF METAL ION HYDROLYSIS BY COAGULATION. III.1 ALUMINUM2
E. Matijević (1961)
10.1016/S0378-5173(98)00404-9
Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.
C. Olbrich (1999)
10.1016/0021-9797(85)90129-8
Inclusion of structural forces in the theory of stability of colloids and films
N. Churaev (1985)
10.1016/S0142-9612(00)00231-3
Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
I. M. van der Lubben (2001)
10.1023/A:1012029517394
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
A. Florence (2004)
10.1007/S003960050353
Agglutination kinetics of F(ab′)2 coated polymer colloids
J. Molina-Bolívar (1998)
10.1016/J.JCIS.2004.08.186
Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior.
T. López-León (2005)
10.1016/S0939-6411(99)00039-9
Polymeric micelles - a new generation of colloidal drug carriers.
M. Jones (1999)
10.1023/A:1007582332491
Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core as a Novel Colloidal Carrier for the Delivery of Oligonucleotides
G. Lambert (2004)
10.1016/J.JCIS.2006.07.031
Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
M. J. Santander-Ortega (2006)
10.1016/S1773-2247(06)50061-9
Chitosan nanocapsules: a new carrier for nasal peptide delivery
C. Prego (2006)
10.1016/0001-8686(82)85006-9
Hydration forces between mica surfaces in electrolyte solutions
R. Pashley (1982)
10.1016/S0378-5173(97)00083-5
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
10.1021/JP803796A
Hofmeister Effects in Colloidal Systems : Influence of the Surface Nature
T. Lopez-Leon (2008)
10.1006/JCIS.1994.1113
Electrolyte induced aggregation of gold particles on solid surfaces
D. Thompson (1994)
10.1016/S0927-7765(99)00157-5
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Tobío (2000)
10.1007/s11095-006-9570-8
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
C. Prego (2006)
10.1615/CRITREVTHERDRUGCARRIERSYST.V18.I6.30
Capture of stealth nanoparticles by the body's defences.
S. Moghimi (2001)
10.1021/LA981445S
How Proteins Stabilize Colloidal Particles by Means of Hydration Forces
J. Molina-Bolívar (1999)
10.1016/0005-2736(91)90268-D
Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size.
T. Allen (1991)



This paper is referenced by
10.1016/j.colsurfb.2010.10.019
Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability.
M. J. Santander-Ortega (2011)
Engineering of polymeric nanoparticles based on structure-activity relationships (SARs) for oral drug delivery
U. Odunze (2018)
10.1177/0883911512447492
Colloidal stability and “in vitro” antitumor targeting ability of lipid nanocapsules coated by folate–chitosan conjugates
Azahara Rata-Aguilar (2012)
10.1007/S11051-011-0548-Z
Aggregation kinetics of CeO2 nanoparticles in KCl and CaCl2 solutions: measurements and modeling
Kungang Li (2011)
10.1016/j.colsurfb.2015.06.001
Complexation and release of DNA in polyplexes formed with reducible linear poly(β-amino esters).
Azahara Rata-Aguilar (2015)
10.1039/c7nr05851a
Robust oil-core nanocapsules with hyaluronate-based shells as promising nanovehicles for lipophilic compounds.
J. Szafraniec (2017)
10.1039/C2SM26389K
Hydration forces as a tool for the optimization of core–shell nanoparticle vectors for cancer gene therapy
M. J. Santander-Ortega (2012)
10.1016/J.JDDST.2017.07.012
Colloids for drug delivery to the brain
M. J. Santander-Ortega (2017)
10.1007/978-3-642-19792-5_3
Polymeric Nanocapsules: Concepts and Applications
F. Poletto (2011)
10.1016/j.ijpharm.2016.05.034
Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.
Raquel Abellan-Pose (2016)
10.1007/978-3-642-19792-5
Nanocosmetics and nanomedicines
R. Beck (2011)
10.1016/j.biomaterials.2015.04.049
Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules.
P. Sánchez-Moreno (2015)
10.33263/briac94.037043
Relationship between the process variables and physicochemical features of liquid-core nanocapsules produced via nanoprecipitation
J. D. Echeverri (2019)
10.1038/srep18423
Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycol
Cristiano Farace (2016)
10.1155/2015/415289
Bone Regeneration from PLGA Micro-Nanoparticles
I. Ortega-Oller (2015)
10.1016/j.ejpb.2018.09.023
Influence of the surface properties of nanocapsules on their interaction with intestinal barriers
Irene Santalices (2018)
10.1021/acs.jpcb.5b02043
Polycation-sodium lauryl ether sulfate-type surfactant complexes: influence of ethylene oxide length.
L. F. Vleugels (2015)
10.1021/la5012555
Understanding the colloidal stability of the mesoporous MIL-100(Fe) nanoparticles in physiological media.
E. Bellido (2014)
10.1016/J.CARBPOL.2011.01.037
Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin
Xiaoying Ying (2011)
10.1002/adhm.201400755
Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
E. Bellido (2015)
10.1007/s00396-012-2669-z
Chitosan-based nanocapsules: physical characterization, stability in biological media and capsaicin encapsulation
F. Goycoolea (2012)
10.3390/pharmaceutics11080388
Formulation, Colloidal Characterization, and In Vitro Biological Effect of BMP-2 Loaded PLGA Nanoparticles for Bone Regeneration
T. Del Castillo-Santaella (2019)
10.1021/bm401103t
Synthesis and characterization of lipid immuno-nanocapsules for directed drug delivery: selective antitumor activity against HER2 positive breast-cancer cells.
P. Sánchez-Moreno (2013)
10.1016/j.ijpharm.2015.05.031
Design of the interface of edible nanoemulsions to modulate the bioaccessibility of neuroprotective antioxidants.
M. Plaza-Oliver (2015)
10.1021/ja204305b
Interaction of monovalent ions with hydrophobic and hydrophilic colloids: charge inversion and ionic specificity.
C. Calero (2011)
10.1016/j.colsurfb.2011.03.020
Development and characterization of nanocapsules comprising dodecyltrimethylammonium chloride and κ-carrageenan.
A. Rosas-Durazo (2011)
10.1016/j.colsurfb.2019.04.006
Carbamide peroxide nanoparticles for dental whitening application: Characterization, stability and in vivo/in situ evaluation.
F. V. Lima (2019)
10.2174/0929867325666180601101859
Coating Matters: Review on Colloidal Stability of Nanoparticles with Biocompatible Coatings in Biological Media, Living Cells and 
Organisms
J. Schubert (2018)
Nanotecnologia y sus aplicaciones en la industria de alimentos - Nanotechnology and its applications in the food industry
J. D. Jaimes (2017)
10.1016/j.cis.2013.10.027
Block copolymers at interfaces: interactions with physiological media.
A. Torcello-Gómez (2014)
Obtention de nanoparticules à base de polymères : étude fondamentale et application au développement de nanocapsules à usage pédiatrique
C. Huertas (2011)
Self-organization of polyelectrolytes : as mediated by surfactants, dyes and ions
L. Vleugels (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar